• Aucun résultat trouvé

Detailed Information Standard

N/A
N/A
Protected

Academic year: 2021

Partager "Detailed Information Standard"

Copied!
2
0
0

Texte intégral

(1)

BBF RFC 67 Detailed Information Standard

BBF RFC 67: Detailed Information Standard

Peter Culviner, Nathaniel Pantalone, Mary Sagstetter, Sarah Sandock, Justin Vrana, Yue Wu

26 October 2010

1. Purpose

The purpose of this standard is to increase the required information that must accompany any parts submitted to the Registry of Standard Biological Parts. This will give users of the parts better assurance of their authenticity and promote better Registry maintenance.

2. Relation to other BBF RFCs

RFC 67 may relate to RFC 52, but a draft of RFC 52 could not be found for comparison.

3. Copyright Notice

Copyright (C) The BioBricks Foundation (2010). All Rights Reserved.

4. Create a .zip File

Persons submitting physical DNA to the Registry of Standard Biological Parts, MUST create a .zip file for each part that SHALL include, but SHALL NOT be limited to, the following files:

• Testing documents that contain data and models for the part E.g. Excel files, .pdf files, etc.

• A detailed protocol of each test conduct on or with the part.

• A GenBank file including the sequence and feature information of the part and the plasmid that it is submitted in.

• The forward and reverse sequence files of the part, including any and all junctions created in the cloning of the part.

The following MAY be included in the .zip file as further evidence of the part: • Any gels observed during the procedure of cloning the part, with the lanes

properly identified.

• Any other experience or identifiable characteristics of the part. E.g. .txt, .pdf, etc. The .zip file should be named in the following way: PartNumber_PlamidName.zip E.g. BBa_K318000_pSB1C3.zip

(2)

5. Upload the .zip File

The part .zip file MUST be uploaded to the part's specific page on the Registry of

Standard Biological Parts' website with a link providing access to the .zip file for anyone to download. If the part is submitted by an iGEM team, a link MUST be provided to the .zip file from that team's wiki page.

6. Author’s Contact Information

Peter Culviner – pculviner@wisc.edu Nathaniel Pantalone – pantalone@wisc.edu Mary Sagstetter – mary.sagstetter@gmail.com Sarah Sandock – sandock@wisc.edu

Justin Vrana – vrana@wisc.edu Yue Wu – ywu37@wisc.edu

References

Références

Documents relatifs

methodology for the development of large scale electronic systems, the study team considers this as a point of departure and a foundation on which further

The present study shows that the potency estimates for rituximab bioactivities in vitro using participant in house methodologies were in good agreement when the different

They further point out that “His [Saul’s] literal blindness is, in some ways, a symbol of a more figurative blindness to what was beyond him and outside him.” 289 Johnson points

Current political developments in Nepal, India, Pakistan and China Ind the implications of these developments for resea rch carried out by European scholars.. The

14 files submitted by States having no elements inscribed, best safeguarding practices selected or requests for International Assistance greater than US$25,000 approved, and the 9

Reaffirms that the communities, groups and, where appropriate, individuals concerned are essential participants at all stages of the identification and inventorying of

Recalling that the Twenty-second World Health Assembly, in resolution WHA22.6, decided that from 1968 new Members shall be assessed in accordance with the practice followed by

2 Until a refrigerator-stable vaccine becomes available, however, varicella vac- cine will not be incorporated into the recommend- ed immunization schedule in Canada, as most